ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell carcinoma, human epidermal growth factor receptor 2 (HER2) positive gastric/gastroesophageal junction carcinoma, HER2-expressing breast cancer, and other solid tumors. The company's pre-clinical products include ALTA-002, a SIRPa TRAAC that offers ways to engage the innate and adaptive immune response to cancer. ALX Oncology Holdings Inc. has a collaboration agreement with Merck for a Phase 2 trial evaluating ALX148 in combination with pembrolizumab with and without chemotherapy in patients with head and neck cancer; Zymeworks on a Phase 1 trial evaluating ALX148 with the HER2-targeting bispecific antibody zanidatamab in patients with HER2-expressing breast cancer and other solid tumors; and Tallac Therapeutics for the development, manufacturing and commercialization of a novel class of cancer immunotherapeutics. It also has a license agreement with Selexis SA and Crystal Bioscience, Inc. The company was founded in 2015 and is headquartered in South San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of ALX Oncology Holdings Inc..
ALX Oncology Holdings Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of ALX Oncology Holdings Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of ALX Oncology Holdings Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of ALX Oncology Holdings Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of ALX Oncology Holdings Inc. and all latest updates of the company are provided.
The 2025 version of ALX Oncology Holdings Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 ALX Oncology Holdings Inc.- Key Facts
2.2 ALX Oncology Holdings Inc.- Geographic Locations
2.3 ALX Oncology Holdings Inc.- Subsidiaries and Affiliates
2.4 ALX Oncology Holdings Inc.- Business Divisions
2.5 ALX Oncology Holdings Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. ALX Oncology Holdings Inc. Strategic Analysis Review
3.1 ALX Oncology Holdings Inc.- Key Strategies
3.2 ALX Oncology Holdings Inc.- Company Outlook Statement
3.3 ALX Oncology Holdings Inc.- SWOT Analysis
3.3.1 ALX Oncology Holdings Inc.- Key Strengths
3.3.2 ALX Oncology Holdings Inc.- Key Weaknesses
3.3.3 ALX Oncology Holdings Inc.- Potential Opportunities
3.3.4 ALX Oncology Holdings Inc.- Potential Threats
3.4 ALX Oncology Holdings Inc.- Key Competitors
4. Business Description of the Company
4.1 ALX Oncology Holdings Inc.- Business Overview
4.2 ALX Oncology Holdings Inc.- Operations by Segment
5 Products and Services Details
5.1 ALX Oncology Holdings Inc.- Key Products
5.2 ALX Oncology Holdings Inc.- Key Service Areas
5.3 ALX Oncology Holdings Inc.- Key Brands
6 Company Developments
6.1 ALX Oncology Holdings Inc.- Company History
6.2 ALX Oncology Holdings Inc.- Latest Developments
7 Financial Analysis
7.1 ALX Oncology Holdings Inc.- Income Statements
7.2 ALX Oncology Holdings Inc.- Balance Sheet
7.3 ALX Oncology Holdings Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 ALX Oncology Holdings Inc.- Direct Competitors
8.2 ALX Oncology Holdings Inc.- Competitor Financial Ratios comparison
8.3 ALX Oncology Holdings Inc.- Competitor Stock Charts Comparison
8.4 ALX Oncology Holdings Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
